Indian dermatology therapeutics Market reports by Insights10 - HTML preview

PLEASE NOTE: This is an HTML preview only and some elements such as links or page numbers may be incorrect.
Download the book in PDF, ePub, Kindle for a complete version.

Image 1

Image 2

Image 3

A sample report on

Indian Dermatological

Therapeutics Market

Analysis

Includes Market Size, Market Segmented by Types and Key Competitors (Data forecasts from 2021 – 2030F) www.insights10.com

Image 4

Image 5

This report presents a strategic analysis of the Indian Dermatology Therapeutics market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, characteristics, main players, trends and insights, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Indian Dermatology Therapeutics market, and offers unmatched value, accuracy, and expert insights

Image 6

Image 7

• Market Overview

• Growth Drivers & Restraints

• Major Dermatology Disease

Table of

• Market Segmentation

• Major Market Share

Contents

• Competitive Landscape

• Key Company Profiles

• Healthcare Policies & Regulatory Framework

• Factors Driving Future Growth

• Conclusion

Image 8

Image 9

Image 10

Table of Contents

1. Indian Dermatology Therapeutics Market Overview…………………………………………..…………………………………....…...........7

1.1 Background

1.2 Introduction

1.3 Market size and forecast

2. Market Growth Drivers and Restraints …………………………………………………………………….…………………………………….11

2.1 Market Growth Drivers

2.1.1 Increase in incidence of skin diseases 2.1.2 Awareness regarding skin diseases

2.1.3 Rising number of working women

2.1.4 Demand for topical dermatology drugs 2.1.5 Easy accessibility of the products

2.1.6 Government Initiatives

2.2 Market Restraints

2.2.1 Serious side effects of drugs

2.2.2 Competitors in Market

4

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 11

Image 12

Image 13

Table of Contents (continued)

3. Major Types of Dermatology Diseases…..…………………………………………………………………………………..………………..20

3.1 Eczema

3.2 Tinea Pedis

3.3 Urticaria/Angioedema

3.4 Atopic Dermatitis

3.5 Acne

4. Dermatology Market Segmentation………………………..…………………………………………………………………..……….….….23

4.1 By Disease Type

4.2 By Drug Class

4.3 By Route of Administration

4.4 By End Users

4.5 By Distribution Channel

5. Dermatology Major Products Market Share…………………………………………………………...…………..….......…………….….31

5.1 Market Analysis, Insights and Forecast - By Revenue 5

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 14

Image 15

Image 16

Table of Contents (continued)

6. Competitive Landscape……………………………………………………………………………………………………………….……………....33

6.1 Major Players

6.2 Products in Pipeline

7. Key Company Profiles (Company Overview, Product & Services, Strategies & Financials ) ….…………………………………..……..…...36

7.1 Sun Pharma

7.2 GlaxoSmithKline

7.3 Glenmark Pharmaceuticals

7.4 Galderma

7.5 USV Private Limited

8. Healthcare Policies and Regulatory Landscape………………………………….………………………………………………...……………..42

8.1 Regulatory Framework of Indian Dermatology Therapeutics Market

9. Factors Driving Future Growth………………………………………………………………………………………………………………….…...45

9.1 Future Opportunities

10. Conclusion………………………. …………………………………………………………………………………………………….………….…...47

10.1 Strategic Recommendations

6

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 17

Image 18

Indian Dermatology Therapeutics Market Analysis 1. Overview

Image 19

Image 20

Image 21

1.1 Background

Skin diseases are responsible for significant morbidity worldwide, but they do not get due importance in national health planning and policies in several countries. Although mortality due to skin diseases is low, they contribute to significant disability, and the non-fatal burden of skin and subcutaneous diseases is more than that of cardiovascular diseases in India

In India, there were 4.07 million (95% uncertainty interval 2.65–6.19 million) years lived with disability due to skin and subcutaneous diseases in 1990, which increased to 6.26 million (95% uncertainty interval 4.12-9.35 million) in 2017. Although the number of years lived with disability has increased by 53.7% between 1990 and 2017, the increase in age-standardised years lived with disability rates was only 1.52%

The high burden of skin and subcutaneous diseases demand that they be given due importance in the national programmes and health policy of India

8

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 22

Image 23

Image 24

1.2 Introduction

As people age, the risk of developing skin-related disorders increases, due to factors, such as changes in the connective tissue, reduction in the skin’s strength and elasticity, and reduction in secretions from sebaceous glands

Skin conditions pose a significant threat to patient’s well-being, mental health, ability to function, and social participation

In India, Dermatitis (atopic, seborrheic and contact) contributed maximum to years lived with disability (1.40Mn, 95% uncertainty interval:0.82–2.21) followed by urticaria (1.02Mn, 95% uncertainty interval 0.06-1.44) with percentage increases of 48.9% and 45.7%, respectively

Infections and infestations contributed to nearly 30 % of the total years lived with disability due to skin and subcutaneous diseases (fungal skin diseases- 12.6%, viral skin diseases-10.0% and scabies- 10.3%) 9

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 25

Image 26

Image 27

1.3 Market Size & Forecast

Indian Dermatology Therapeutics Market Size US$ Mn Key Analysis

Indian Dermatology Therapeutics market size stood at XX

around US$ xx Bn in 2021 and is projected to reach US$

xx Bn by 2030, exhibiting a CAGR of around xx% during the forecast period

The derma market has grown by approximately 4.5% per year on an average (CAGR). The current market size of the Dermatology segments in India is approximately $xx xx

Mn, growing rapidly at about xx%. In terms of revenue, the face care products was dominating the market with 57.22% share in 2020

The increasing incidence of Dermatology diseases and increasing levels of awareness-related disease progression, etiology, and available therapies are leading 2021

2022F

2023F

2024F

2025F

2026F

2027F

2028F

2029F

2030F

to a high growth of Dermatology therapeutics in India 10

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 28

Image 29

Indian Dermatology Therapeutics Market Analysis 2. Growth Drivers & Restraints

Image 30

Image 31

Image 32

Image 33

Image 34

Image 35

Image 36

Image 37

Image 38

Image 39

2.1 Market Growth Drivers

Rise in the

incidence of skin

Demand for Topical

diseases

Dermatology drugs

Awareness

Easy

Market

regarding Skin

Accessibility of

Drivers

Diseases

the products

Rising number

Government

of working

Initiatives

women

12

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 40

Image 41

Image 42

Image 43

Market Growth Drivers

2.1.1 Rise in the incidence of skin diseases

With the rise in the aging population, Dermatology care is likely to receive particular attention

Sample

As people age, the risk of developing skin- related disorders increases due to factors, such as changes in the connective tissue, reduction in the skin's strength and elasticity, and reduction in secretions from sebaceous glands

13

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 44

Image 45

Image 46

Image 47

Market Growth Drivers (continued)

2.1.2 Awareness regarding skin diseases

Increase in improvement of awareness regarding skin health in India

Sample

Sample

14

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 48

Image 49

Image 50

Image 51

Market Growth Drivers (continued)

2.1.3 Rising number of working women

Rising number of working women and is leading to higher demand for personal care product

Sample

Sample

Sample

15

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 52

Image 53

Image 54

Image 55

Market Growth Drivers (continued)

2.1.4 Demand for Topical Dermatology drugs

Demand for topical Dermatology drugs has increased due to increased population. It directly affects the growth of Dermatology Market

Drugs such as anti-inflammatory agents, anti-infective, local Sample

anaesthetics, cleansers, and emollients to treat acne Sample

16

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 56

Image 57

Image 58

Image 59

Market Growth Drivers (continued)

2.1.5 Easy accessibility of the products

Easy accessibility of the products through company websites and online channels, and doorstep delivery are driving the market

Sample

Sample

Sample

17

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 60

Image 61

Image 62

Image 63

Market Growth Drivers (continued)

2.1.6 Government Initiatives

The initiatives taken by the government are expected to contribute to the growth of the dermatology market in India

For example, PMJY, is funded tertiary health coverage scheme, which provides cashless surgical treatments for Sample

various ailments, including Dermatology problems Sample

18

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 64

Image 65

Image 66

Image 67

Image 68

2.2 Market Restraints

2.2.1 Serious side effects

2.2.2 Competitors in market

Due to the presence of numerous globally

Serious side effects of certain classes of operating companies, the Indian skincare derma therapeutic drugs are expected to restrain the cosmetics market is fragmented, which is

market growth in the near future

prompting the players to launch new products Sample

Sample

19

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 69

Image 70

Indian Dermatology Therapeutics Market Analysis 3. Major Dermatology Diseases

Image 71

Image 72

Image 73

3. Major Dermatology Diseases

3.1

3.2

3.3

Eczema

Tinea Pedis

Urticaria ⁄Angioedema

Chronic urticaria is a relatively common

In India, at least one in five

About 10% of the total

condition in India and most cases have no children suffer from eczema,

population may be affected by

specific allergic trigger and remain

also known as atopic

dermatophyte infections of the

idiopathic

dermatitis. “Since the

toe clefts

underlying causes are

incompletely known, we

The condition is more common

Autoimmune causes have been found to

undertook a study to identify

in adult males than in females

be associated with up to 30- 40% cases

correlates of the disease”

It is important to look for physical

urticarias such as pressure urticaria in

chronic cases

21

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 74

Image 75

Image 76

Image 77

Image 78

Major Dermatology Diseases

3.4

3.5

Atopic Dermatitis

Acne

Atopic Dermatitis (AD) is hereditary and

In India, about 12 percent between 20 to 29

the most common type of eczema. AD

years of age had acne problems.

almost always starts in infancy or before Excess oil production, pores becoming

age 5

clogged by sticky skin cells, bacteria and inflammation directly contributed to acne problems

22

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 79

Image 80

Indian Dermatology Therapeutics Market Analysis 4. Market Segmentation

Image 81

Image 82

Image 83

Image 84

Image 85

Image 86

Image 87

Image 88

Snapshot of Dermatology Therapeutics Market Segmentation By Disease Type

By Drug Class

Dermatology

Market

By Route Of Administration

Segmentation

By End Users

By Distribution Type

24

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 89

Image 90

Image 91

Image 92

Image 93

Image 94

Image 95

Image 96

Snapshot of Dermatology Therapeutics Market Segmentation ROUTE OF

DISEASE TYPE

DRUG CLASS

ADMINISTRATION

END USERS

DISTRIBUTION CHANNEL

• Acne

• Anti-infectives

• Oral

• Home Care

• Pharmacy

• Dermatitis

• Corticosteroid

• Topical

• Hospital

Store

• Psoriasis

s

• Parenteral

• Dermatolog

• Retail Store

• Skin

• Calcineurin

Administratio

y

• Online

Cancer

inhibitors

n

Clinics

• Alopecia

• Retinoids

• Rosacea

• Antirheumatic

25

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 97

Image 98

Image 99

4.1 Market Segmentation: By Disease Type Indian Dermatology Therapeutic Market Share by Disease type Key Insights

2022

Approximately 80 percent of Indian are affected by acne between the onset of puberty and 30 years of age. By the end of 2026, the number of people affected by acne in India is estimated to reach 23 million at a compound annual growth rate (compound average growth rate) of 0.5 percent.

In India, the incidence of melanoma of the skin in the SAMPLE

North region is 1.62 for males and 1.21 for females for every 1,00,000 people. The overall incidence of nonmelanoma skin cancer is the highest in the Northeast region, going as high as 5.14 for men and 3.98 for women for every 1,00,000 people.

▪ Content

Acn

Eczem

Atopic

Skin

Tinea

e

a

Dermatiti

Cancer

Pedis

s

26

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 100

Image 101

Image 102

4.2 Market Segmentation: By Drug Type

Indian Dermatology Therapeutics Market Share by Drug Type Key Insights

2022

The biologics segment is expanding at a large scale during the forecast period owing to the increasing regulatory approval of biologics.

Anti-infectives are medicines that work to prevent or treat infections, they include antibacterials, antivirals, antifungals and antiparasitic medications.

SAMPLE

Topical corticosteroids are effective in a number of dermatoses. Dermatotherapy has always been a combination of art and science.

Anti-infectives Corticosteroids

Calceneurin

Retinoids

Antirhematic

Sample

Inhibitors

27

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 103

Image 104

Image 105

Image 106

4.3 Market Segmentation: Route of Administration Indian Dermatology Therapeutic Market Share by Route of Key Insights

Administration, 2022

In Indian dermatology therapeutics market, the topical segment held a large share of the market owing to the Parenteral

rise in the demand for topical Dermatology drugs such as administration

anti-inflammatory agents, anti-infective, local anesthetics, cleansers, and emollients to treat acne.

Oral

SAMPLE

Topical

Topical

Oral

Parenteral

administration

28

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 107

Image 108

Image 109

Image 110

4.4 Market Segmentation: By End Users

Indian Dermatology Therapeutic Market Share by End User, Key Insights

2022

Hospitals provide medical, diagnostic, and treatment services to inpatients and some outpatient dermatology services, which is holding largest share of the dermatology market

Large number patients are being treated at home, which SAMPLE

is holding market share following hospitals in dermatology market

Hospitals

Homecare

Dermatology Clinics

29

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 111

Image 112

Image 113

4.5 Market Segmentation: By Distribution Channels Indian Dermatology Therapeutic Market Share by Distribution Key Insights

Channel, 2022

It is expected that the pharmacy and retail store category will lead throughout the forecast period.

This is due to the availability of a broad range of over-the-counter derma products, which are available in the pharmacy and retail stores.

SAMPLE

However, with the increasing trend toward online shopping and due to Covid-19 impact, people are preferring to make an online purchase and due to this online category is also witnessing faster growth in the dermatology market Pharmacy Store

Retail Store

Online

30

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 114

Image 115

Indian Dermatology Therapeutics Market Analysis 5. Major Product Market Share

Image 116

Image 117

Image 118

Image 119

5.1 Major Dermatology Products Market Share Indian Dermatology Therapeutics Major

Key Insights

Products Market Share

SAMPLE

Top Brands in Dermatology Therapeutics Market Brand 1

Brand 2

Brand3

Brand 4

44

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 120

Image 121

Indian Dermatology Therapeutics Market Analysis 6. Competitive Landscape

Image 122

Image 123

Image 124

6.1 Major Players Revenue (Current and Forecast) Revenue of Major Dermatology Market Players ($Bn) 2021

2022F

2023F

2024F

2025F

2026F

2027F

2028F

2029F

2030F

Sun Pharma

$XX

$XX

$XX

$XX

$XX

$XX

$XX

$XX

$XX

$XX

GlaxoSmithKline

$XX

$XX

$XX

$XX

$XX

$XX

$XX

$XX

$XX

$XX

Glenmark

$XX

$XX

$XX

$XX

$XX

$XX

$XX

$XX

$XX

$XX

Pharmaceuticals

Galderma India Private

$XX

$XX

$XX

$XX

$XX

$XX

$XX

$XX

$XX

$XX

Limited

USV Private Limited.

$XX

$XX

$XX

$XX

$XX

$XX

$XX

$XX

$XX

$XX

34

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 125

Image 126

Image 127

Image 128

6.2 Products in Pipeline

Lipidor AB has penned an agreement with Cadila Pharmaceuticals to conduct a Phase III study for Lipidor’s drug candidate AKP-02.

AKP-02 is an antipsoriasis medicine that combines the active substances calcipotriol and betamethasone with Lipidor’s spray-based AKVANO technology

Content

Sample

48

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 129

Image 130

Indian Dermatology Therapeutics Market Analysis 7. Key Company Profiles

Image 131

Image 132

Image 133

Image 134

Image 135

Image 136

Image 137

Image 138

Image 139

7.1 Sun Pharma

Company Profile

Company Name: Sun Pharma

Year of Establishment: 1983

Headquarter: India

Revenue: $4.5 Bn

Website www.sunpharma.com

Sample

37

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 140

Image 141

Image 142

Image 143

Image 144

Image 145

Image 146

Image 147

Image 148

7.2 GlaxoSmithKline

Company Profile

Company Name: GlaxoSmithKline

Year of Establishment: 2000

Headquarter: United Kingdom

Revenue: $xx Bn

Website: www.gsk.com

Sample

38

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 149

Image 150

Image 151

Image 152

Image 153

Image 154

Image 155

Image 156

Image 157

7.3 Glenmark Pharmaceuticals

Company Profile

Company Name: Glenmark Pharmaceuticals Year of Establishment: 1977

Headquarter: Mumbai, India

Revenue: $xx Bn

Website: www.glenmarkpharma.com

Sample

39

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 158

Image 159

Image 160

Image 161

Image 162

Image 163

Image 164

Image 165

Image 166

7.4 Galderma India Private Limited

Company Profile

Company Name: Galderma India Private Limited

Year of Establishment: 1981

Headquarter: SA Lausanne, Switzerland Revenue: $3.4 Bn

Website:

www.galderma.com

Sample

40

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 167

Image 168

Image 169

Image 170

Image 171

Image 172

Image 173

Image 174

Image 175

7.5 USV Private Limited

Company Profile

Company Name: USV Private

Limited

Year of Establishment: 1959

Headquarter: Mumbai, India

Revenue: $2.3 Bn

Website: www.usvindia.com

Sample

41

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 176

Image 177

Indian Dermatology Therapeutics Market Analysis 8. Healthcare Policy and Regulatory Landscape

Image 178

Image 179

Image 180

Image 181

Image 182

Image 183

Image 184

8.1 Regulatory Framework of India Dermatology Therapeutics Market The Indian Association of Dermatologists, The journey that culminated in the

Venereologists and Leprologists (IADVL),

formation of IADVL as we know it today

the largest representing official society of took its first flight in 1947 when Dr. UB

Indian Dermatologists was established in its Narayan Rao, conceived the idea to create present form on 28th January, 1973

an association of Dermatologists and

Venereologists

IADVL is the national association of Indian A framework regarding rules was approved on medical specialists who manage patients

July 26, 1948 and the association started its with skin disorders, sexually transmitted work on establishing local branches in other infections (STIs) or leprosy. The association states. IADVL also happens to be the world’s works for the betterment of the specialty by 2nd largest Association of Dermatologists holding academic meetings, printing a

behind the American Academy of Dermatology journal (print version & online)

43

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 185

Image 186

Image 187

Image 188

Image 189

Regulatory Framework of India Dermatology Therapeutic Market

The Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) organization is ever committed to serving the public in the domains of dermatology. In lieu of this, IADVL observes several days of clinical significance including Leprosy day, Vitiligo day, World Skin Health Day to name a few

IADVL has a wing dedicated to Community outreach programs which not only help in taking quality skin care to the rural remote areas but also promote awareness on skin hygiene, equipping the local medical personnel to manage the common skin conditions and to refer the complicated cases to higher referral centers

Indian Dermatology Online Journal (IDOJ) is a bimonthly open access print journal of Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) 44

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 190

Image 191

Indian Dermatology Therapeutics Market Analysis 9. Factors Driving Future Growth

Image 192

Image 193

Image 194

9. Future Opportunities

The new vendors within the Dermatology

Diagnostic Devices and Therapeutics market face powerful competition from established international vendors as they struggle with technological innovations, dependability, and quality problems

.

The Indian Journal of Dermatology

The prime strategically activities

has always played a progressive

within the market are initiated by

role of acting as a medium for the

the key players which incorporate

ever- changing developments of

product developments, mergers,

scientific research in dermatology in

and acquisitions, partnerships, etc.

this part of the world

Future

Opportunities

46

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 195

Image 196

Indian Dermatology Therapeutics Market Analysis 10. Conclusion

Image 197

Image 198

Image 199

Image 200

Image 201

Image 202

10.1 Strategic Recommendations

Dermatology in the new

The importance of skin to the

Dermatologists may

millennium must focus on the

individual will not diminish,

themselves opt out of treating

needs, hopes, and

and funding agencies should

conditions which governance

satisfaction of those who

recognize this. The costs of

deems important. An example

consider themselves to have

treating skin diseases will

would be all breaks in surface

skin liaments. Governments

always be an issue, and the

continuity of the skin which

can change this by declaring

case for treating skin

other professions might wish

some unidentified needs to be

diseases will have to be

to take over as leg ulcers, the

important and thus fundable,

made in a competitive world

diabetic foot ulcer, the

while others are deemed

filled with many life-

pressure sore, or burns

unimportant

threatening diseases

48

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 203

Image 204

Methodology & Scope

Image 205

Image 206

Image 207

Research Methodology

Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions

We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government and regulatory published material, technical journals, trade magazines, and paid data sources

For forecasting, the following parameters are considered:

Market drivers and restraints along with their current and expected impacts

Technological scenario and expected developments

End use industry trends and dynamics

Trends in the consumer behavior

Regulatory scenario and expected developments

Current capacity and expected capacity additions up to 2030

We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected market growth rate

We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions

All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)

The currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 208

Image 209

Image 210

Analysis Methodology

Our Analysis Methodology involves three critical stages: Market Data Analysis &

Interpretation and

Data Collection

Statistical Model

Presentation

Analysis &

Market Trends

Interpretation

Secondary

Data

Market Sizing

Insights

& Analysis

Primary

Interviews

Data Triangulation

Presentation

& Validation

& Reporting

51

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 211

Image 212

Image 213

Data Triangulation and Data Validation Top Down Approach

Final

Market

Final Market size break up to

Size

rest of segmentation

Validation from

Arriving at market size

Primary

of each segment

Interview

Summarization of revenue

generated from companies

Validation from

to arrive at total market size

Primary

Interview

Revenue generated by products &

Final

services offered by companies

Bottom

Su -up

mm A

ar nal

y

ysis

Bottom Up Approach

52

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 214

Image 215

Image 216

Image 217

Image 218

Image 219

Image 220

Image 221

Image 222

Key Benefit for Stakeholders from this report The study provides an in-depth analysis of the Indian dermatology therapeutics market with current trends and future estimations to elucidate the imminent investment pockets Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and quantitative industry variables

Comprehensive analysis of factors that drive and restrict the market growth is provided Comprehensive quantitative analysis of the industry from 2021 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities

Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors 53

A Sample Report on Indian Dermatology Therapeutics Market I Confidential

Image 223

Time Frame

Report Attribute

Details

Quantitative Units

Revenue in USD Million/Billion (Mn/Bn)

Base Year for

2021

Estimation

Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends,

Report Coverage

Company Profiles, Competitive Landscape,

Regulatory Landscape, Future Opportunities Report Customization (5 working days) with purchase. We will provide you with data that is Customized Report

currently not a part of our scope as a part of 2022-Forecast

customization

2030

Period

Pricing and purchase

Avail customized purchase options to meet options

your exact research needs

Image 224

Image 225

What kind of Data is Presented

in this Report?

This report presents data, which is:

Reliable

Expert-verified

Real

Comprehensive

Easy to read

The report is prepared

The data is prepared by

Allowing you to

Covers everything you

You do not have to be a

using a proven

a team of highly qualified

confidently make

would need to know

market expert to

methodology and

& experienced research

smarter business

about the market

understand what really is

insightful research

analysts & vetted by our

and strategic

including market size,

happening on the market

local associates

decisions

competitive analysis &

and how it works

much more

www.insights10.com

Image 226

Image 227

About

Image 228

Image 229

Image 230

Image 231

Lifesciences Market

Research Reports you

can trust

A large database of over 30,000 syndicated market research reports in pharmaceuticals and

healthcare sector at global, regional as well as country level. We also provide customized research reports tailor made to suit your needs

www.insights10.com

Image 232

Image 233

Image 234

Image 235

Get Insights to take

informed Business

Decisions

Insights10 is a healthcare focused market research firm founded with an aim of being an insights driven company in the data driven world and delivering actionable insights that can drive decision and strategy making process for

businesses

www.insights10.com

Image 236

Image 237

Market Research Reports

across various domains of healthcare

Pharmaceuticals

Digital

Medical

Healthcare

OTC &

Clinical

(Diseases & Drugs) Health

Devices

Services

Nutraceuticals

Trials

Image 238

Image 239

Market Research Reports

1

6

Full-Time Engagement

Customized Reports

2

7

Conference Coverage

Our

Primary Research

3

Services

8

Competitive Intelligence

Strategic Research Projects

4

9

Regulatory Compliance

Database Services

5

10

Report Subscription Services

Image 240

Image 241

Image 242

Our Research Process

01

02

03

04

05

Identification of

Market

Collection of

Collaboration

Verification &

Data

Dynamics

Data

of Data

Analysis

www.insights10.com

Image 243

Statistical Databases

Company Websites/Annual Reports

Data

Sources

Trade Publications

We have access to multiple highly

Online Databases

reliable free and subscription data

sources. We have many years of

experience to understand which

Published Research Reports

sources are more dependable for what

and which to prefer for the reliable and

Whitepapers

latest information.

Press Releases of Key Market Players

www.insights10.com

Image 244

Image 245

Over the years, we have developed an in-depth experience of executing market analysis at global, regional & country specific level in life sciences.

Our team has

conducted market

research across 62+

global markets in

America, Europe,

Middle East, Africa and

Asia Pacific regions

Research Projects Done

Image 246

Image 247

Image 248

Image 249

Image 250

Project Leadership Team

Dr. Purav Gandhi

Mukesh Nayak

Ritu Baliya

Dhruv Joshi

Founder & CEO

Head - Marketing

Engagement Manager

Consultant

Purav is a physician and an

Mukesh is an engineering graduate

Ritu has over 6 years of experience in

Dhruv Joshi is an engineer and has done

entrepreneur with 12+ years of

with an MBA in Marketing. He is a

strategy building, market assessments,

Masters in Hospital Administration with

experience in Healthcare & Life

seasoned healthcare market

market sizing, and RWE for global MNC

over 4 years of experience in the

Sciences industry spanning across

research & marketing professional

healthcare & biopharma clients across healthcare and life science industry. He

strategy, market access, health

with a progressive experience of over

diff. markets (America, Europe, Africa,

has gained proficiency in market

informatics and RWE, digital health,

20 years in Life Sciences, Pharma

APAC and Middle East). Her areas of

research, market assessment, and

analytics and data science. Purav

and Medical Device sectors . With an

expertise include: Indentifying emerging

developing insights from it. He has

studied medicine from Gujarat

in-depth understanding of primary

trends in life sciences industry,

worked on various consulting projects

University and also completed his MBA

research, he has conducted

Competitor landscape assessment,

across different geographies including

from IIM-Kozhikode. Purav started his

hundreds of interviews of various

Disease opportunity assessments etc.

Asia, Europe, US, MENA. He has been

career with Deloitte working on strategy

stakeholders in pharma & healthcare

She is a pro in secondary and primary

aligned in working for sector reports of

consulting engagements and also co-

& completed several research

research with a deep domain expertise

various geographies along with market

founded ConvergeHealth by Deloitte.

projects across life sciences industry.

in healthcare sector.

sizing and forecasting.

Image 251

Image 252

Image 253

Image 254

Image 255

Image 256

Image 257

Image 258

Image 259

Image 260

Image 261

Image 262

Image 263

Image 264

Image 265

Image 266

Image 267

Image 268

7 years of experience working with leading organizations in pharma, MedTech and healthcare domain. Some of our recent clients are mentioned below

… and many more

Image 269

Image 270

Image 271

We would be happy to help.

Web: www.insights10.com

Email: insights@insights10.com

Call: (+91) 931 639 7935

Whatsapp: (+91) 931 639 7935

You may also like...

  • Benefits of Tantra Yoga
    Benefits of Tantra Yoga Free Previews by Empower Balance
    Benefits of Tantra Yoga
    Benefits of Tantra Yoga

    Reads:
    30

    Pages:
    29

    Published:
    Oct 2024

    Tantra Yoga is an ancient practice that intertwines physical, mental, and spiritual elements to achieve profound personal growth. Unlike many traditional form...

    Formats: PDF, Epub, Kindle, TXT

  • Google Plus Money Making Tactics
    Google Plus Money Making Tactics Free Previews by Paul Mesther
    Google Plus Money Making Tactics
    Google Plus Money Making Tactics

    Reads:
    19

    Pages:
    34

    Published:
    Jun 2024

    Google Plus Money Making Tactics: The Most Complete and Easy to Follow Google Cash Blueprint Ever is your ultimate guide to unlocking the financial potential ...

    Formats: PDF, Epub, Kindle, TXT

  • Heart Melodies
    Heart Melodies Free Previews by Eman Nazir
    Heart Melodies
    Heart Melodies

    Reads:
    13

    Pages:
    21

    Published:
    May 2024

    "Heart Melodies" is a captivating collection of poems that weaves the intricate emotions of the human experience into lyrical verses. Each poem resonates wit...

    Formats: PDF, Epub, Kindle, TXT

  • Ultrabot Guide: boost your youtube channel
    Ultrabot Guide: boost your youtube channel Free Previews by Ultrabot
    Ultrabot Guide: boost your youtube channel
    Ultrabot Guide: boost your youtube channel

    Reads:
    17

    Pages:
    21

    Published:
    May 2024

    Discover the secrets to YouTube success with the \"UltraBot Guide: Boost Your YouTube Channel\" book. This comprehensive guide offers step-by-step instruction...

    Formats: PDF, Epub, Kindle, TXT